849357-53-5

Basic information

• Product Name: 4-bromo-2-fluoro-N,N-dimethylbenzenesulfonamide
• Synonyms: 4-bromo-2-fluoro-N,N-dimethylbenzenesulfonamide
• CAS NO: 849357-53-5
• Molecular Formula: C₈H₉BrFNO₂S
• Molecular Weight: 282.1299632
• Mol File: 849357-53-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-bromo-2-fluoro-N,N-dimethylbenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-fluoro-N,N-dimethylbenzenesulfonamide(849357-53-5)
• EPA Substance Registry System: 4-bromo-2-fluoro-N,N-dimethylbenzenesulfonamide(849357-53-5)

Safety Data

• Hazardous Substances Data: 849357-53-5(Hazardous Substances Data)

Upstream product

• 216159-03-4 4-bromo-2-fluorobenzenesulfonyl chloride 
• 124-40-3 dimethyl amine 

Downstream Products

• 945244-24-6 4-bromo-2-cyano-N,N-dimethylbenzenesulfonamide 
• 945239-70-3 5'-(1-(benzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-4-(N,N-dimethylsulfamoyl)-2'-methylbiphenyl-3-carboxylic acid 

Relevant articles and documents

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

SUBSTITUTED PHENYLLUREAS AND PHENYLAMIDES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted phenylureas and phenylamides of formula (I), to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions.

Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions

Vanilloid receptor ligand compounds corresponding to formula I: a process for producing such compounds, pharmaceutical compositions containing them, and the use of such compounds to treat pain and various other vanilloid receptor mediated conditions.